 | Up a level |
Eisert, A., Scheffier, M., Gogl, L., Frank, R., Scheel, A., Merkelbach-Bruse, S., Michels, S., Fischer, R., Buettner, R. and Wolf, J. (2015). Clinical and genetic presentation of high-level cMET-amplified Non-small cell lung cancer (NSCLC) with adenocarcinoma histology. Oncol. Res. Treat., 38. S. 16 - 17. BASEL: KARGER. ISSN 2296-5262
Eisert, A., Scheffler, M., Frank, R., Gogl, L., Scheel, A., Merkelbach-Bruse, S., Michels, S., Fischer, R., Buttner, R. and Wolf, J. (2015). Clinical and genetic presentation of high-level cMET-amplified Non-small cell lung cancer (NSCLC) with adenocarcinoma histology. Eur. J. Cancer, 51. S. S646 - 1. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852
Frank, R., Scheffler, M., Michels, S., Eisert, A., Fischer, R., Koenig, K., Merkelbach-Bruse, S., Serke, M., Ko, Y. D., Gerigk, U., Geist, T., Heukamp, L., Buettner, R. and Wolf, J. (2015). KEAP1-mutations and NFE2L2-mutations in patients with non-small cell lung cancer (NSCLC). Eur. J. Cancer, 51. S. S645 - 1. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852
Frank, R., Scheffler, M., Michels, S., Eisert, A., Gogl, L., Fischer, R., Koenig, K., Merkelbach-Bruse, S., Serke, M., Ko, Y. -D, Gerigk, U., Geist, T., Heukamp, L., Buettner, R. and Wolf, J. (2015). KEAP1-mutations and NFE2L2-mutations in patients with non-small cell lung cancer (NSCLC). Oncol. Res. Treat., 38. S. 268 - 269. BASEL: KARGER. ISSN 2296-5262
Frank, R., Scheffler, M., Michels, S., Koenig, K., Merkelbach-Bruse, S., Serke, M., Ko, Y. -D, Gerigk, U., Geist, T., Heukamp, L., Buettner, R. and Wolf, J. (2014). Occurrence and characteristics of KEAP1-mutations in patients with non-small cell lung cancer (NSCLC). Oncol. Res. Treat., 37. S. 8 - 9. BASEL: KARGER. ISSN 2296-5262
Koleczko, S., Schaepers, C., Scheffler, M., Ihle, M., Kostenko, A., Michels, S., Fischer, R., Nogova, L., Brandes, V., Abdulla, D., Ueckeroth, F., Thurat, M., Frank, R., Eisert, A., Bitter, E., Woempner, C., Gogl, L., Merkelbach-Bruse, S., Buettner, R. and Wolf, J. (2016). A comprehensive analysis of potentially targetable genetic aberrations and clinical findings in 821 patients with squamous-cell NSCLC - a comparison of NGM and TCGA LUSC data. Ann. Oncol., 27. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041